Log in
Login
Password
Remember
Lost password
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Shares  >  Italian Stock Exchange  >  DiaSorin SpA    DIA

Delayed Quote. Delayed BATS Europe - 08/03 11:30:00 am
42.185 EUR   +0.92%
07/30 DIASORIN : H1'15 Results
07/21 DIASORIN : Enters into Distribution Agreement with Beckman Coulter D..
07/20 DIASORIN : and Beckman Coulter sign a distribution agreement for Chi..
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Italian Stock Exchange
07/28/2015 07/29/2015 07/30/2015 07/31/2015 08/03/2015 Date
41.14(c) 41.46(c) 41.56(c) 41.8(c) 42.42 Last
54 907 35 120 54 915 125 617 126 728 Volume
+0.64% +0.78% +0.24% +0.58% +1.48% Change
More quotes
Financials (€)
Sales 2015 486 M
EBIT 2015 147 M
Net income 2015 95,4 M
Finance 2015 82,1 M
Yield 2015 1,53%
Sales 2016 516 M
EBIT 2016 158 M
Net income 2016 103 M
Finance 2016 105 M
Yield 2016 1,61%
PER 2015 24,06
PER 2016 22,34
EV / Sales 2015 4,65x
EV / Sales 2016 4,33x
Capitalization 2 339 M
More Financials
Company
DiaSorin SpA engages in the development, production, and marketing reagent kits for in vitro diagnostics.It operates through the Immunodiagnostics and Molecular Diagnostics segments.The Immunodiagnostics segment manufactures and distributes immunoreagent kits based on chemiluminescence,... 
More about the company
Surperformance© ratings of DiaSorin SpA
Trading Rating : Investor Rating :
More Ratings
Latest news on DIASORIN SPA
07/30 DIASORIN : H1'15 Results
07/21 DIASORIN : Enters into Distribution Agreement with Beckman Coulter Diagnostics
07/20 DIASORIN : and Beckman Coulter sign a distribution agreement for China
07/20 DIASORIN : And Beckman Coulter Sign A Distribution Partnership For Hepatitis And..
06/23 DIASORIN : Announces New Webinar Highlighting Syphilis Diagnosis
05/28 DIASORIN : launches the test for Campylobacter
05/18 DIASORIN SPA : ex-dividend day for annual dividend
04/29 DIASORIN : launches the test for Sepsis
More news
Sector news : Diagnostic & Testing Substances
04:20p MEDTRONIC : CMS Grants New Technology Add-On Payment for Inpatient Use of Medtro..
09:00a BAXALTA : Blood Publishes Phase III Data on Baxalta’s Investigational Trea..
08:31a BAXALTA : Announces Expanded CMS Coverage for Medicare PI Patients to Receive At..
More sector news : Diagnostic & Testing Substances


Comments 
Advertisement
Chart DIASORIN SPA
Duration : Period :
DiaSorin SpA Technical Analysis Chart | DIA | IT0003492391 | 4-Traders
Full-screen chart
Technical analysis trends DIASORIN SPA
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions